Gilbert, AZ, United States of America

Anthony Helmstetter

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Anthony Helmstetter in Precision Medicine**

Introduction

Anthony Helmstetter, an accomplished inventor residing in Gilbert, Arizona, has made significant strides in the field of precision medicine. With two patents to his name, Helmstetter’s work focuses on enhancing treatment effectiveness for colorectal cancer patients through comprehensive molecular profiling.

Latest Patents

Helmstetter's latest patents involve advanced methods for classifying entities for FOLFOX treatment and next-generation molecular profiling. These innovations utilize comprehensive data regarding the molecular status of patient samples. By comparing this data with patient responses to treatments, he has been able to identify biomarker signatures that predict the response or non-response to FOLFOX, a chemotherapy regimen consisting of 5-fluorouracil, leucovorin, and oxaliplatin. His patents also detail data structures, processing techniques, and machine learning models aimed at predicting treatment effectiveness based on a patient’s specific biomarker profile.

Career Highlights

Currently employed at Caris MPI, Inc., Helmstetter's contributions have paved the way for improvements in the precision of cancer treatment. His innovative approaches facilitate clinicians in selecting the most effective treatments tailored to individual patients' molecular profiles.

Collaborations

Helmstetter collaborates with skilled professionals such as Jim Abraham and David Spetzler, further enhancing the research and application of predictive models in oncology. These partnerships exemplify the collaborative environment at Caris MPI, Inc., where cutting-edge innovations are developed.

Conclusion

Anthony Helmstetter stands out as a noteworthy inventor in the realm of precision medicine. His patents and collaborative ventures highlight a dedication to improving patient outcomes in cancer treatment through advanced technological applications. As his work continues to evolve, it promises to significantly impact the future of oncology and treatment personalization.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…